The Center for Real Estate's 2023 World Real Estate Forum is soliciting projects, ideas and start-ups of interest to our sophisticated audience of 300+ attendees for the Tech Showcase. The Tech Showcase will feature a broad range of concepts in Real Estate, or adjacent sectors, including (but not limited to): PropTech, ConstructionTech, ClimateTech, Urbanization, Data Science, Mobility, Sustainability, Clean Energy or Social Equity.
Please submit the brief application by Monday, May 1, 2023.
Royal Dutch Shell, a global energy company, seeks startups for automating management of their offshore assets. They are looking to develop digital tools to reduce the cost and improve the safety of inspection, maintenance, and repair of these offshore assets.
Looking for 8-10 startups to present their technologies at the 2022 MIT Japan Conference. This will be a virtual event to be held on Jan 20, 9:00 - 10:30 AM (Tokyo time) / Jan 19, 7:00 - 8:30 PM ET (US time).
MIT Startup Exchange is looking for 10 MIT-connected startups to present and exhibit at the MIT Japan Conference in Tokyo on Friday, January 27, 2023.
P&G is looking to drive agile in-market pilots in Europe with the goal of scaling successful services & solutions.
P&G is looking for solutions in material testing & visual analysis.
Gerdau is looking for startups able to perform visual inspection on welding work, using computational image and ML/AI. Companies would be invited to present to a group of ten of Gerdau's biggest fabricator clients in the US on Oct. 8th. These presentations would be part of Gerdau's Customer Advisory Board that has a focus on digital transformation and solutions.
Early-stage backers of Rivian, JIMCO seeks MIT spin-off startups that are initiating or improving commercialization efforts across multiple industries - eg. energy, water, mobility.
We seek three startups to present in front of approximately 200 individuals from industry, academia, and government, plus a stand-up booth during all networking breaks and a buffet luncheon. Startups will be considered from any segment of healthcare, including novel medical devices, digital health, pharma/nutrition, etc.